TrialThe Journal of allergy and clinical immunology2013
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
Florence E Roufosse et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
78 papers cite itlatest 60 shown
this paperpooled ittrialcites it